Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapport Therapeutics (RAPP) Change in Account Payables (2023 - 2026)

Rapport Therapeutics (RAPP) has 4 years of Change in Account Payables data on record, last reported at $2.3 million in Q1 2026.

  • On a quarterly basis, Change in Account Payables rose 1145.95% to $2.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $4.3 million, a 345.53% increase, with the full-year FY2025 number at $2.2 million, up 740.17% from a year prior.
  • Change in Account Payables reached $2.3 million in Q1 2026 per RAPP's latest filing, up from $1.2 million in the prior quarter.
  • Over the last five years, Change in Account Payables for RAPP hit a ceiling of $2.3 million in Q1 2026 and a floor of -$1.1 million in Q1 2024.
  • A 4-year average of $502909.1 and a median of $633000.0 in 2023 define the central range for Change in Account Payables.
  • Peak YoY movement for Change in Account Payables: plummeted 489.13% in 2025, then soared 1145.95% in 2026.
  • Tracing RAPP's Change in Account Payables over 4 years: stood at $725000.0 in 2023, then fell by 10.62% to $648000.0 in 2024, then surged by 81.79% to $1.2 million in 2025, then skyrocketed by 95.67% to $2.3 million in 2026.
  • Business Quant data shows Change in Account Payables for RAPP at $2.3 million in Q1 2026, $1.2 million in Q4 2025, and -$179000.0 in Q3 2025.